Abstract
Commercially available paclitaxel (PTX)-coated balloons (DCB) employ different PTX composition, PTX dose, and excipient. These balloons decrease restenosis compared to uncoated balloons (POBA), but not have been compared against each other. This study compares 4-year outcomes between patients treated with PTX-coated and POBAs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
